Mark Eisner
Evp And Chief Medical Officer at Vir Biotechnology, Inc. (VIR)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $50K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Feb 26SEC | VIRVir Biotechnology, Inc. | Sell Plan | 1,616155,913 held (−1%) | $9.53 | $15K | +4.5% |
| Feb 26SEC | VIRVir Biotechnology, Inc. | Sell Plan | 1,889154,024 held (−1%) | $9.82 | $19K | +1.4% |
| Feb 24SEC | VIRVir Biotechnology, Inc. | Sell Plan | 2,089157,529 held (−1%) | $7.45 | $16K | +33.7% |
- Sell
Evp And Chief Medical Officer Mark Eisner sold $15K of VIR at $9.53 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp And Chief Medical Officer Mark Eisner sold $19K of VIR at $9.82 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp And Chief Medical Officer Mark Eisner sold $16K of VIR at $7.45 — pre-scheduled 10b5-1 plan sale.